In Korea, the Ministry of Food and Drug Safety (MFDS) is in charge of regulating pharmaceutical products and services.
Pharmaceutical companies submit a Gabunat Drug Master File in Korea (Gabunat KDMF) to the MFDS, which includes comprehensive information about the production, processing, facilities, materials, packaging, and testing of Gabunat. The MFDS reviews the Gabunat KDMF as part of the drug registration process and uses the information provided in the Gabunat KDMF to evaluate the safety and efficacy of the drug.
After submitting a Gabunat KDMF to the MFDS, the registered manufacturer can provide importers or distributors with the registration number without revealing confidential information to Korean business partners. Applicants seeking to register their Gabunat API can apply through the Korea Drug Master File (KDMF).
click here to find a list of Gabunat suppliers with KDMF on PharmaCompass.